AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19

NCT04649775 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped no eligible participants

Conditions

Corona Virus Infection
Respiratory Rate
Hypoxia
Covid19

Interventions

DEVICE: AirFLO2

Sponsor

Duke University

Collaborators

[object Object]